Honkgong News report about Cytodyn and Leronlimab!
Post# of 148167
(Total Views: 1380)
Posted On: 04/10/2020 1:28:06 PM
Re: nmbr1stckpckr #26765
Honkgong News report about Cytodyn and Leronlimab!
https://hk.news.appledaily.com/international/...QVEWKG3HY/
Translation:
[Wuhan Pneumonia ● Special Topic] Ventilator can be stopped in a few days for severely ill patients in New York
15 hours ago
Scientists around the world are still working hard to study the treatment of Wuhan pneumonia. Two Wuhan pneumonia patients in New York City used an experimental drug to treat AIDS and cancer, and their condition improved rapidly. They had to be treated with a ventilator in the intensive care unit. After improvement, it can be transferred to the general hospital. The doctor in charge of this clinical trial said that if the drug continues to work, it is expected to be approved by the US Food and Drug Administration (FDA) within a few weeks.
Related news: 【Wuhan Pneumonia ● Special Topic】 Trump's "Magic Drug" Controversial Clinical Test Has Been Blocked and Some Hospitals Stop
The drug factory CytoDyn was used as a drug for the treatment of HIV and breast cancer, "leronlimab", and had undergone small preliminary tests on seven Wuhan patients with severe pneumonia in New York. The results convinced them that the drug has the potential to treat severe patients with pneumonia in Wuhan. They believe that although this drug cannot fight the Wuhan pneumonia virus, it can suppress the cytokine storm (Cytokine storm), that is, a large number of immune cells cause the same serious damage as the infection, which will cause pneumonia and cause the patient's life-threatening death.
Doctors at the New York Hospital used two injections, one injection on each side of the abdomen, to inject the drug into seven critically ill patients. The first patient to improve was in his 70s, and the drug was effective almost immediately. The patient had to repeatedly insert the larynx three days before receiving this treatment. After treatment, the snorkel can be removed. The second improved patient no longer needs blood pressure medicine to relieve the pressure of the disease. The other two also showed signs that the severe inflammation that caused their lungs to fail in organs was subsiding. One week after the first injection, the hospital injected a second dose of "leronlimab" into these patients. Only one of the seven patients had no stable improvement.
The United States does not currently recognize Wuhan pneumonia therapy, but the CytoDyn drug is already the latest drug to help save patients' lives. If it continues to work, it is expected to be approved by the FDA in six weeks. CyotoDyn Chairman Dr Nader Pourhassan said that the pharmaceutical factory will allow 75 other patients with mild or moderate symptoms of Wuhan pneumonia to use the drug. Recognized.
British "Daily Mail"
https://hk.news.appledaily.com/international/...QVEWKG3HY/
Translation:
[Wuhan Pneumonia ● Special Topic] Ventilator can be stopped in a few days for severely ill patients in New York
15 hours ago
Scientists around the world are still working hard to study the treatment of Wuhan pneumonia. Two Wuhan pneumonia patients in New York City used an experimental drug to treat AIDS and cancer, and their condition improved rapidly. They had to be treated with a ventilator in the intensive care unit. After improvement, it can be transferred to the general hospital. The doctor in charge of this clinical trial said that if the drug continues to work, it is expected to be approved by the US Food and Drug Administration (FDA) within a few weeks.
Related news: 【Wuhan Pneumonia ● Special Topic】 Trump's "Magic Drug" Controversial Clinical Test Has Been Blocked and Some Hospitals Stop
The drug factory CytoDyn was used as a drug for the treatment of HIV and breast cancer, "leronlimab", and had undergone small preliminary tests on seven Wuhan patients with severe pneumonia in New York. The results convinced them that the drug has the potential to treat severe patients with pneumonia in Wuhan. They believe that although this drug cannot fight the Wuhan pneumonia virus, it can suppress the cytokine storm (Cytokine storm), that is, a large number of immune cells cause the same serious damage as the infection, which will cause pneumonia and cause the patient's life-threatening death.
Doctors at the New York Hospital used two injections, one injection on each side of the abdomen, to inject the drug into seven critically ill patients. The first patient to improve was in his 70s, and the drug was effective almost immediately. The patient had to repeatedly insert the larynx three days before receiving this treatment. After treatment, the snorkel can be removed. The second improved patient no longer needs blood pressure medicine to relieve the pressure of the disease. The other two also showed signs that the severe inflammation that caused their lungs to fail in organs was subsiding. One week after the first injection, the hospital injected a second dose of "leronlimab" into these patients. Only one of the seven patients had no stable improvement.
The United States does not currently recognize Wuhan pneumonia therapy, but the CytoDyn drug is already the latest drug to help save patients' lives. If it continues to work, it is expected to be approved by the FDA in six weeks. CyotoDyn Chairman Dr Nader Pourhassan said that the pharmaceutical factory will allow 75 other patients with mild or moderate symptoms of Wuhan pneumonia to use the drug. Recognized.
British "Daily Mail"
(8)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼